TMBIM6 has been reported to exhibit elevated expression levels in various malignancies, including fibrosarcoma, cervical, breast, lung, nasopharyngeal, and prostate cancers [19, 22]. This evidence concerns the gene TMBIM6 and prostate carcinoma.